Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
CNBC· 2 日前... would stop developing the twice-daily version of its experimental weight loss pill< ... ...
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
CNBC· 20 小時前Pfizer's twice-daily version of its experimental weight loss pill has now joined a long ...
Why Pfizer's latest stumble in the obesity market is a boon for Eli Lilly
CNBC· 2 日前Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and ...
Pfizer Stops Developing Weight-Loss Pill
Bloomberg· 2 日前Pfizer stops developing its experimental weight-loss pill. More than half of patients in the ...
Pfizer Shares Drop After Axing Twice-Daily Weight-Loss Pill
Bloomberg· 2 日前Pfizer Inc. is dropping development of an experimental weight-loss pill due to side effects, a ...
Pfizer drops twice-daily version of obesity pill over side effects
Reuters· 2 日前Pfizer has a once-daily version of the weight-loss pill still in the development. It hopes a ...
Japan trials OTC sales of 'morning-after' pill - RTHK
RTHK· 5 日前Japan on Tuesday began trial sales of over-the-counter "morning-after" contraceptive ...
Multivitamins aren't a 'cheat pill' and not everyone needs to take them, doctor ...
CNBC· 3 日前You probably know at least one person who swears by taking a daily multivitamin — or you take ...
Weight-Loss Drugs Are a Gold Mine, and Just as Elusive
Bloomberg· 2 日前... Pfizer Inc. announced that it’s dropping development of an experimental weight-loss pill a ...
Pfizer Pulls Experimental Twice-Daily Weight Loss Drug—Shares Slide 6% To Multiyear Low
Forbes· 2 日前... won’t move forward with trials for a twice-daily regimen of its weight-loss pill< ... ...
